Latest News – PSNC Main site
Pharmaceutical Services Negotiating Committee
COVID-19 update: Nominated pharmacy feature added to the NHS App
The NHS App now has a new feature that allows patients to view and change their EPS pharmacy nomination. Being able to update nominations in the NHS App means patients can more easily choose the pharmacy that is right for them during the COVID-19 pandemic and beyond. The NHS App team at NHS Digital have...
Retrospective price adjustment for Omeprazole 10mg/5ml and 20mg/5ml oral suspension SF and Melatonin 1mg/ml oral solution AF
Omeprazole Two Omeprazole licensed liquid preparations became available on the market in March 2020. Following representations from PSNC to account for the licensed products now on market, Department of Health and Social Care (DHSC) and the National Assembly of Wales have retrospectively determined from March 2020: The addition of (with special container status applied): Omeprazole...
Further medicines added to the list of medicines that cannot be parallel exported from the UK
The Department of Health and Social Care (DHSC) and the Medicines and Healthcare products Regulatory Agency (MHRA) has announced that an additional 52 medicines have been added to the list of medicines which must not be parallel exported from the UK. The restriction will be in place from 00:00am 01 April 2020. The new restrictions...
Contractor Update: Pharmacies to be required to open on Good Friday and Easter Monday
On the evening of 1st April, in the COVID-19 Primary Care Bulletin email, NHS England and NHS Improvement (NHSE&I) stated: “pharmacies will need to be open on Good Friday and Easter Monday as part of the wider NHS response to the pandemic”. Since then we have been pressing NHSE&I for urgent confirmation on this matter...
COVID-19: Revised PPE guidance issued
Public Health England’s (PHE) updated guidance on the use of personal protective equipment (PPE), issued today, now recommends use of fluid-resistant surgical masks in pharmacies when working in an area with possible or confirmed cases and where pharmacy teams are unable to maintain 2 metres social distance. The guidance for community pharmacy staff is included...
COVID-19 Update: Easter 2020 Opening Hours
The four national community pharmacy representative organisations have this evening (1 April) issued a joint statement on Easter 2020 opening hours. AIM, CCA, NPA and PSNC have been informed this afternoon that NHS England and NHS Improvement (NHSE&I) may shortly announce that community pharmacies must open for at least some time on Good Friday and...
COVID-19 Update: Protection of staff and managing supply
The latest COVID-19 preparedness letter for community pharmacy from NHS England and NHS Improvement (NHSE&I) provides further guidance and information on support for pharmacy teams. The letter can be read in full here but we have summarised the key points below. Protection of staff Social distancing alongside installation of bollards, physical barriers or screens is...
COVID-19 Negotiations Update: Delivery Service, PPE and Opening Hours
PSNC has today (1 April) issued an update on some of its most significant ongoing COVID-19 related negotiations with NHS England and NHS Improvement (NHSE&I) and the Department of Health and Social Care (DHSC). Urgent discussions on the Pandemic Delivery Service, Easter opening hours and Personal Protective Equipment (PPE) are ongoing and we will publish...
Prescription charge rises to £9.15
Today (1st April) the NHS prescription charge increases to £9.15 per prescription item. The cost of prescription pre-payment certificates (PPCs) has also increased, with the price of a three-month PPC at £29.65 (an increase of 55 pence) and a 12-month PPC at £105.90 (an increase of £1.90). PPCs offer savings for those needing four or...
End of the Flu Vaccination Service 2019/20 (1st April 2020)
The national community pharmacy Flu Vaccination Service 2019/20 has now ended. Community pharmacy contractors are therefore reminded not to administer any further vaccinations under this service. Claims will be accepted by the NHS Business Services Authority (NHSBSA) within six months of administration of the vaccination or by 31st August 2020, whichever date is earlier, in accordance with...
PharmaTimes: PharmaTimes Website RSS
PharmaTimes - The latest news in healthcare and life sciences - PharmaTimes Website RSS
Pfizer wins EU approval for MabThera biosimilar
The drug will be available to treat certain cancers and autoimmune conditions
Novartis, Incyte to test Jakavi for coronavirus-linked cytokine storm
Early clinical evidence suggests that the JAK inhibitor could reduce the number of patients requiring intensive care and mechanical ventilation
Sanofi unveils new data for Dupixent in children with dermatitis
Nearly three times as many children achieved clear or almost clear skin when treated with Dupixent and standard-of-care topical corticosteroids
Funding support for community pharmacy during coronavirus
The advanced funding injection is designed to support pharmacies to provide critical services throughout the pandemic
Health secretary lays out plans for 100,000 coronavirus tests a day
Testing for those with a medical need and the most critical workers is to rise to 25,000 a day by mid-to-late April
UK team close to delivering new COVID-19 test
It is hoped that the new technology will deliver up to 1,000 test results per machine in 24 hours
Gilead starts late-stage trials in the UK of potential COVID-19 therapy
The study will initially involve 15 sites across the UK
NIHR launches new Centre for Engagement and Dissemination
The Centre will bring activities in patient and public involvement, engagement and participation and research dissemination under one roof.
AZ licences Movantik rights to RedHill
AstraZeneca has completed its deal to sublicense certain rights to Movantik to RedHill Biopharma
Positive early data from siltuximab COVID-19 trial
One-third (33%) of patients experienced a clinical improvement with a reduced need for oxygen support
NICE publishes second set of rapid COVID-19 guidelines
The guidelines advise clinicians on modifying care to reduce patients’ exposure to COVID-19 and how to balance the risks and benefits of treatment during the pandemic
EU research-based industry unveils COVID-19 commitments
As of this morning - Wednesday April 1 - the current recorded case count for COVID-19 (coronavirus) in the UK has hit 25,150, with 1,789 deaths.
Ethris, Neurimmune work on inhalable COVID-19 therapy
Ethris GmbH and Neurimmune AG are working together on developing an inhalable treatment for COVID-19
Novel micro-RNA therapeutic hits early targets in ischemic heart diseases
Earlier this year, Horizon announced a new collaboration and license agreement with Mammoth Biosciences.
Eli Lilly, Sitryx announce autoimmune alliance
Eli Lilly recently announced plans to postpone most new COVID-19-unrelated study starts.
Every sector of the pharmaceutical market is represented under one roof, this year in Madrid. Attending CPhI Worldwide is the most cost effective way to establish new business relationships, meet with global partners and stay updated on the latest industry trends.
Find out more: https://www.cphi.com/europe/